Why is GKB Ophthalmics falling/rising?

As of 22-Sep, GKB Ophthalmics Ltd is experiencing a decline in its stock price, currently at 69.51, which reflects a decrease of 0.85 or 1.21%. The stock has underperformed its sector by 1.01% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 4.39%. Additionally, GKB Ophthalmics has shown significant underperformance over various time frames, with a 1-month return of -13.10% and a year-to-date decline of -29.61%. The company's financial health is concerning, highlighted by a weak long-term fundamental strength with a -166.65% CAGR growth in operating profits over the last five years and a negative EBITDA, indicating that the stock is trading at risky valuations.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as the Sensex has gained 0.46% over the past week while GKB Ophthalmics has lost 2.80%. This consistent underperformance against the benchmark is evident over the last three years, where the stock has failed to generate positive returns compared to the BSE500. The decline in investor participation, with a significant drop in delivery volume, further exacerbates the stock's challenges, suggesting a lack of confidence among investors. Overall, the combination of weak financial metrics, poor profitability, and negative market sentiment contributes to the ongoing decline in GKB Ophthalmics' stock price.